Cyclosporine treatment of anal furunculosis in 26 dogs

被引:34
作者
Hardie, RJ
Gregory, SP
Tomlin, J
Sturgeon, C
Lipscomb, V
Ladlow, J
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA
[2] Queen Mothers Hosp Anim, Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England
关键词
D O I
10.1111/j.1748-5827.2005.tb00267.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
OBJECTIVES: To evaluate the effect of cyclosporine on anal furunculosis lesions in 26 dogs. METHODS: Lesions were graded as mild in 11 dogs, moderate in eight and severe in seven. Each dog was treated with approximately 4 mg/kg cyclosporine orally every 12 hours until the lesions resolved or showed no further improvement. Residual lesions were resected surgically. RESULTS: Eighteen dogs (69 per cent) experienced complete resolution, seven (27 per cent) improved but had residual lesions and one (4 per cent) showed no improvement. The mean duration of treatment until resolution or no further improvement was 8.8 weeks (range four to 24 weeks). Nine dogs (35 per cent) experienced recurrence. Six were from the group that had shown complete resolution and three were from the group that had surgery. Fifteen dogs (58 per cent) developed side effects to cyclosporine, although none required treatment to be discontinued. Mean duration of follow-up was 6.8 months (range one to 20 months). CLINICAL SIGNIFICANCE: Cyclosporine was effective at resolving or reducing anal furunculosis lesions in 25 of 26 dogs (96 per cent). However, residual or recurrent lesions remain a potential problem, and surgical resection or long-term cyclosporine treatment may be necessary in some dogs.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 57 条
[1]  
Akagi S, 2000, INT J MOL MED, V5, P389
[2]   Tumour necrosis factor and inflammatory bowel disease [J].
Armstrong, AM ;
Gardiner, KR ;
Kirk, SJ ;
Halliday, MI ;
Rowlands, BJ .
BRITISH JOURNAL OF SURGERY, 1997, 84 (08) :1051-1058
[3]   Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].
Baert, FJ ;
D'Haens, GR ;
Peeters, M ;
Hiele, MI ;
Schaible, TF ;
Shealy, D ;
Geboes, K ;
Rutgeerts, PJ .
GASTROENTEROLOGY, 1999, 116 (01) :22-28
[4]  
BENNETT WM, 1986, ANNU REV MED, V37, P215
[5]   CYCLOSPORINE-ASSOCIATED ORGANIC MENTAL-DISORDERS IN LIVER-TRANSPLANT RECIPIENTS [J].
CRAVEN, JL .
PSYCHOSOMATICS, 1991, 32 (01) :94-102
[6]   IMMUNOPATHOLOGY OF ANAL FURUNCULOSIS IN THE DOG [J].
DAY, MJ .
JOURNAL OF SMALL ANIMAL PRACTICE, 1993, 34 (08) :381-389
[7]   PATHOLOGY OF SURGICALLY RESECTED TISSUE FROM 305 CASES OF ANAL FURUNCULOSIS IN THE DOG [J].
DAY, MJ ;
WEAVER, BMQ .
JOURNAL OF SMALL ANIMAL PRACTICE, 1992, 33 (12) :583-589
[8]   Evaluation of once daily treatment with cyclosporine for anal furunculosis in dogs [J].
Doust, R ;
Griffiths, LG ;
Sullivan, M .
VETERINARY RECORD, 2003, 152 (08) :225-+
[9]   Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine [J].
Egan, LJ ;
Sandborn, WJ ;
Tremaine, WJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :442-448
[10]   MANAGEMENT OF PERIANAL FISTULAS - A RETROSPECTIVE STUDY OF 23 CASES [J].
ELKINS, AD ;
HOBSON, HP .
VETERINARY SURGERY, 1982, 11 (03) :110-114